Abstract
Activated protein C (APC) is a major control system of blood coagulation. APC prevents coagulation pathway by degrading Va and VIIIa plasma’s coagulation factors. Protein C activation requires its binding to specific endothelial cell receptor (EPCR). APC binding to EPCR also activates a wide range of defense mechanisms (anti-inflammatory, antiapoptosis…). EPCR expression by cells can be detected by various methods, including immunoanalysis and molecular biology. However, no assays evaluate its functionality. A method, inspired of a standard fibrinoformation time assay, was developed to estimate EPCR ability to bind APC on living cell surface in vitro . Endothelial cells were incubated with APC and fibrinoformation on cells was followed by spectrophotometry (plasma absorbance increases with fibrin polymerization). Membrane-bound EPCR retain APC, thus prolonging fibrinoformation time in a dose-dependent manner. Control was realized with EPCR-negative cells. This new method can be used on any cell type to study the expression of other coagulation receptors.
Cite
CITATION STYLE
Ducros, E., Mirshahi, S., Bermot, C., & Mirshahi, M. (2009). Analysis of Endothelial Protein C Receptor Functionality on Living Cells’. The Open Biochemistry Journal, 03(1), 49–54. https://doi.org/10.2174/1874091x00903010049
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.